Lv41
452 积分 2025-09-17 加入
Tubeimoside II potentiates anti-PD-1 therapy in NSCLC by increasing ferroptosis sensitivity and remodeling immune landscape
13天前
已完结
Luteolin targets peroxiredoxin 2 to augment T-cell-mediated cytotoxicity and suppress lung adenocarcinoma progression
13天前
已完结
Effect of JAK/STAT signaling on anti-PD-L1 immunotherapy efficacy in lung cancer
14天前
已完结
Metabolic reprogramming of NK cells drives anti-tumor immunity
15天前
已完结
Pathology, immunosuppression and NK cell immunotherapy of non-small cell lung cancer
15天前
已完结
Metabolic reprogramming of NK cells drives anti-tumor immunity
1个月前
已完结
Pathology, immunosuppression and NK cell immunotherapy of non-small cell lung cancer
1个月前
已完结
Nebulized Immunotherapy of Orthotopic Lung Cancer by Mild Magnetothermal–Based Innate Immunity Activations
1个月前
已完结
Immunoediting of cancer metastasis by NK cells
1个月前
已完结
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
1个月前
已完结
皖公网安备34019202002308
